potactasol
actavis group ptc ehf - topotecan - uterine cervical neoplasms; small cell lung carcinoma - antineoplastic agents - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5.1).topotecan in combination with cisplatin is indicated for patients with carcinoma of the cervix recurrent after radiotherapy and for patients with stage ivb disease. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.1).
topotecan 4 mg/ml pdr for soln for infusion
fresenius kabi oncology plc - topotecan hydrochloride - pdr for soln for infusion - 4 mg/ml - other antineoplastic agents
topotecan 4 milligram pdr/conc/soln for infus
accord healthcare limited - topotecan (as hydrochloride) - pdr/conc/soln for infus - 4 milligram
topotecan martindale pharma 4 milligram pdr/conc/soln for infus
martindale pharmaceuticals ltd - topotecan hydrochloride - pdr/conc/soln for infus - 4 milligram
topotecan martindale pharma 1 milligram pdr/conc/soln for infus
martindale pharmaceuticals ltd - topotecan hydrochloride - pdr/conc/soln for infus - 1 milligram
topotecan pliva 4 milligram pdr/conc/soln for infus
pliva pharma limited - topotecan hydrochloride - pdr/conc/soln for infus - 4 milligram
topotecan 1mg1ml concentrate for solution for infusion vials
medac uk - topotecan hydrochloride - solution for infusion - 1mg/1ml
topotecan 4mg4ml concentrate for solution for infusion vials
medac uk - topotecan hydrochloride - solution for infusion - 1mg/1ml
topotecan ebewe 1 mg/ml concentrate for soln for inf
ebewe pharma ges.m.b.h nfg. kg - topotecan hydrochloride - concentrate for soln for inf - 1 mg/ml
topotecan kabi
fresenius kabi australia pty limited - topotecan hydrochloride -